Acarix
0.26 SEK
+0.19 %
Less than 1K followers
ACARIX
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+0.19 %
-7.32 %
-13.50 %
-3.17 %
-3.89 %
+21.83 %
-33.23 %
-76.76 %
-96.49 %
Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary artery disease. The company's product is a non-invasive test that is applied with a patch to the patient to analyze sounds from the heart. The business is conducted primarily within the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The headquarters are located in Malmö.
Read moreMarket cap
321.92M SEK
Turnover
376.08K SEK
Revenue
7.36M
EBIT %
-652.31 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
18/5
2026
Interim report Q1'26
17/6
2026
General meeting '26
13/8
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Acarix Changes Publication Date for Q1 2026 Interim Report
Acarix AB’s Annual Report 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools